Pharmaceutical Technology1 天
Treprostinil by United Therapeutics for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.
Pharmaceutical Technology1 天
Ralinepag XR by United Therapeutics for Pulmonary Arterial Hypertension: Likelihood of Approval
Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.